Congestive heart failure required at least one of the following symptoms or signs, new or worsening including: dyspnea at rest, orthopnea, or paroxysmal nocturnal dyspnea, AND radiological evidence of heart failure or worsening heart failure AND additional/increased therapy. Cooper 2011 (C) N Recurrent ischemic chest discomfort, new ischemic electrocardiographic changes, and CK-MB increase above the upper limit of normal and increased by 50% over the previous value. For patients with percutaneous coronary intervention 24 hours previously, CK-MB >3 times the upper limit of normal and increased by >50% over the previous value was required. For patients with coronary artery bypass grafting surgery 24 hours previously, CK-MB >5 times the upper limit of normal and increased by >50% over the previous value was required.
New or worsening HF was defined as 1 of the following occurring >6 hours after randomization: cardiogenic shock or a physician's decision to treat HF with an intravenous diuretic or intravenous vasoactive drug and evidence of pulmonary vascular congestion. ((blood or erythrocyte* or "red cell*" or "red blood cell*" or RBC*) near/5 (transfus* or unit* or infus* or therap*)) #4 ((red cell* or RBC* or erythrocyte* or red blood cell* or whole blood or transfus*) near/5 (use* or usage* or utiliz* or utilis* or requir* or need* or administ* or replac* or support* or strateg* or management or practic* or indicat* or criteri* or standard* or program*)):ab #5 ((red cell* or RBC* or erythrocyte* or blood or transfus*) and (use* or usage* or utiliz* or utilis* or requir* or need* or administ* or replac* or support* or strateg* or management or practic* or indicat* or criteri* or standard* or program*)):ti #6 (leukodeplet* or leukoreduc* or leucodeplet* or leucoreduc* or leukofiltrat* or leucofiltrat*):ti #7
("allogeneic blood" or (unit* near/2 blood) or "allogenic blood" or (blood near/2 exposure) or "donor blood" or "blood product*" or "blood component*" or "blood support") #8
(hemotransfus* or haemotransfus* or hypertransfus* or hemotherap* or haemotherap*) #9 (red cell* or erythrocyte* or blood or RBC*) and transfus* #22 and #25 #27 ((transfus* or "red cell*" or "red blood cell*" or RBC*) near/10 (trigger* or thresh?old* or target* or restrict* or liberal* or aggressive* or conservative* or prophylactic* or limit* or protocol* or policy or policies or practic* or standard*)) #28 ((transfus* or "red cell*" or "red blood cell*" or RBC* or h?ematocrit*) and (level* or critical* or intensive* or h?emorrhag* or bleed*) or hypertransfus 
(erythrocyte* or red cell* or red blood cell* or blood or RBC*) N5 (transfus* or infus* or therap* or unit*) S4 AB ((red cell* or RBC* or erythrocyte* or red blood cell* or whole blood or transfus*) N5 (use* or usage* or utiliz* or utilis* or requir* or need* or administ* or replac* or support* or strateg* or management or practic* or indicat* or criteri* or standard* or program*)) S5 TI ((red cell* or RBC* or erythrocyte* or blood or transfus*) and (use* or usage* or utiliz* or utilis* or requir* or need* or administ* or replac* or support* or strateg* or management or practic* or indicat* or criteri* or standard* or program*)) S6 hemotransfus* or haemotransfus* or hemotherap* or haemotherap* or hypertransfus* S7 TX (red cell* or erythrocyte* or blood or RBC*) and TI (transfus*) S8 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 S9
(MM "Hematocrit") S10 TX ((hemoglobin or haemoglobin or hematocrit* or haematocrit* or HB or HCT) N5 (level* or concentration* or target* or maintain* or rais* or higher or lower or greater or above or below or equal or transfus*)) S11 S9 OR S10 S12 S8 AND S11 S13 TI ((transfus* or red cell* or red blood cell* or RBC* or haematocrit* or hematocrit*) and (level* or critical* or intensive* or haemorrhag* or hemorrhag* or bleed*)) S14 TX ((transfus* or "red cell*" or "red blood cell*" or RBC*) N10 (trigger* or threshold* or target* or restrict* or liberal* or aggressive* or conservative* or prophylactic* or limit* or protocol* or policy or policies or practice* or standard*)) S15 S12 OR S13 OR S14 S16
(MH Clinical Trials+) S17
PT Clinical Trial S18 TI ((controlled trial*) or (clinical trial*)) OR AB ((controlled trial*) or (clinical trial*)) S19 TI ((singl* blind*) OR (doubl* blind*) OR (trebl* blind*) OR (tripl* blind*) OR (singl* mask*) OR (doubl* mask*) OR (tripl* mask*)) OR AB ((singl* blind*) OR (doubl* blind*) OR (trebl* blind*) OR (tripl* blind*) OR (singl* mask*) OR (doubl* mask*) OR (tripl* mask*)) S20
TI randomi* OR AB randomi* S21 MH RANDOM ASSIGNMENT S22 TI ((phase three) or (phase III) or (phase three)) or AB ((phase three) or (phase III) or (phase three)) S23
(TI (random* N2 (assign* or allocat*)) ) OR (AB (random* N2 (assign* or allocat*)) ) S24 MH PLACEBOS S25 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 S26 S12 AND S25
PUBMED (epublications only)
#1 ("erythrocyte transfusion*" OR "red cell transfusion" OR "red cells" OR "red blood cells" OR "red blood cell transfusion" OR "blood transfusion* 
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#1 TS=(("erythrocyte transfusion*" OR "red cell transfusion" OR "red cells" OR "red blood cells" OR "red blood cell transfusion" OR "blood transfusion*" OR RBCs OR "RBC transfusion*" OR hemotransfus* or haemotransfus* or hemotherap* or haemotherap* or hypertransfus*) #2 TS=((hemoglobin or haemoglobin or hematocrit* or haematocrit* or HB or HCT) NEAR/1 (level* or concentration* or target* or maintain* or rais* or higher or lower or greater or above or below or equal or transfus*)) #3 #1 AND #2 #4 TS=((transfus* or "red cell*" or "red blood cell*" or RBC*) NEAR/5 (trigger* or threshold* or target* or restrict* or liberal* or aggressive* or conservative* or prophylactic* or limit* or protocol* or policy or policies or practice* or standard*)) #5 #3 OR #4 #6 TS=(randomi* OR randomly OR "random assignment" OR "random allocation" OR blind* OR "control group*" OR controlled trial OR "controlled study") #7 #5 AND #6 
